Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

1. Knuf, M.
2. Leroux-Roels, G.
3. Rümke, H.C.
4. Abarca, K.
5. Rivera, L.
6. Lattanzi, M.
7. Pedotti, P.
8. Arora, A.
9. Kieninger-Baum, D.
10. Della Cioppa, G.